Peripheral Artery Disease Market Size, Share, Trends, Regional Analysis and Segmentation By Key Companies
Research Reports
May 25, 2022
Market Overview
The industry for peripheral artery disease was $3,524.77 million in 2019 and is predicted to grow to $5,715.12 million by 2027, with a CAGR of 8.5 percent from 2020 to 2027.
The expansion of the Peripheral Artery Disease Market is projected to be hampered by production disruptions of PAD devices plus delays in-hospital procedures caused by the COVID-19 pandemic.
PAD is a common cardiovascular disorder in which constricted arteries restrict blood flow to the limbs. PAD mostly impacts arteries within the legs, but it can also damage arteries carrying blood from the heart to the head, kidneys, arms, and stomach. Accumulation of fats (plaques) in the arterial walls causes blood flow to the limbs, organs, as well as head to be reduced.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1540
Market Segmentation
By Treatment Type
In 2018, the device category accounted for 55.5 percent of the industry for peripheral artery disease. The importance of devices in managing the condition is expected to boost the growth of the peripheral artery disease industry.
By End-User
In 2018, the clinics and hospitals sectors accounted for 48.0 percent of the industry for peripheral artery disease. Because most patients prefer to travel to hospitals or clinics because they may get better care, the worldwide peripheral artery disease industry is poised to increase.
Regional Classification
The Americas’ rise to the top of the regional market is attributable to rising healthcare spending, a high prevalence of diabetes, and a big number of obesity cases.
The European region ranks second in terms of share of the market for peripheral artery disease. Due to increased cardiovascular problems and a growing cigarette smoking population, the European industry is expected to rise at a rapid pace over the forecast timeframe.
Because of the expanding patient share and technological advancements, the Asia Pacific peripheral artery disease pharmaceuticals market size is expected to represent the highest market development capability. Because of their aging populations, Australia, India, and China have a lucrative peripheral artery disease market.
The Middle East as well as Africa’s peripheral artery disease industry is being boosted by a growing number of obesity patients, rising government measures to improve patient care, and attractive compensation policies.
Key Players
Koninklijke Philips NV (Netherlands), Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Bayer AG (Germany), Boston Scientific Corporation (US), Becton, Dickinson, and Company (BD) (US), Terumo Medical Corporation (Japan ), Biotronik (Germany), Cardinal Health (US)
Industry News
The peripheral artery disease business is increasing due to factors besides an increase in the elderly population and, as a result, a rise in the incidence of peripheral artery illnesses, as well as a rise in product approvals. Furthermore, the increase in diabetes cases propels the peripheral artery disease industry forward. Restenosis (recurrence of peripheral artery disease after therapy) is a stumbling block to market expansion.
Furthermore, ever-changing lifestyle patterns such as bad food habits, obesity, excessive alcohol use, smoking, as well as insufficient physical activity make people more prone to peripheral artery disease, driving the market growth.
Other factors driving the market include an increase in preference for minimally invasive endovascular techniques, which have a faster recovery period, less scarring, and fewer post-surgery infections. Furthermore, as illness-causing lifestyle as well as eating habits like tobacco, high consumption of alcohol, as well as smoking cigarettes become more prevalent, demand for peripheral vascular devices is predicted to rise, such as cardiac arrest, blood clotting, as well as other vascular illnesses become more common.
Browse More Related Reports:
Global Avian Influenza Vaccine Market Research Report—Forecast till 2027
Big Data in Healthcare Market Research Report – Global Forecast to 2027
Global Biologics Market Research Report- Forecast to 2027
Bipolar Disorders Treatment Market Research Report – Global Forecast till 2027
Blockchain in Pharmaceutical Supply Chain Management Market Research Report – Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Information:
Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 628 258 0071 Email: sales@marketresearchfuture.com
Tags:
Wire, Research Newswire, English